Dishman Carbogen AmicsNSE:DCAL +0.89%70 PB Ratio is 0.46 as of Jul. 08, 2026, which is 16% below its 10-year median of 0.55. GuruFocus rates NSE:DCAL with a GF Score™ of 70/100 and a GF Value™ of ₹237.37 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,225 Biotechnology companies, Dishman Carbogen Amics ranks better than 95.67% on this metric.
The historical rank and industry rank for Dishman Carbogen Amics's PB Ratio or its related term are showing as below:
NSE:DCAL'
s PB Ratio Range Over the Past 10 Years
Min: 0.16 Med: 0.55 Max: 2.49
Current: 0.46
During the past 13 years, Dishman Carbogen Amics's highest PB Ratio was 2.49. The lowest was 0.16. And the median was 0.55.
NSE:DCAL's PB Ratio is ranked better than 95.67% of 1225
companies
in the Biotechnology industry
Industry Median: 2.92
vs NSE:DCAL: 0.46
During the past 12 months, Dishman Carbogen Amics's average Book Value Per Share Growth Rate was 14.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 8.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Dishman Carbogen Amics was 60.40% per year. The lowest was -0.40% per year. And the median was 9.85% per year.
Back to Basics: PB Ratio
Dishman Carbogen Amics (NSE:DCAL) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Dishman Carbogen Amics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dishman Carbogen Amics PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Dishman Carbogen Amics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Dishman Carbogen Amics (NSE:DCAL) has a PB Ratio of 0.46 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dishman Carbogen Amics and its competitors. This is 16% below median its historical median of 0.55. Over the past decade, Dishman Carbogen Amics' PB Ratio has ranged from 0.16 to 2.49. According to the industry distribution chart, Dishman Carbogen Amics ranks #53 out of 1225 companies in the Biotechnology industry, placing it in the top 4.3%.
Is Dishman Carbogen Amics' PB Ratio too high?
Dishman Carbogen Amics' current PB Ratio of 0.46 is 16% below median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.16 to a high of 2.49. The Biotechnology industry median PB Ratio is 2.92. Dishman Carbogen Amics' value of 0.46 is 84.2% below this industry median. Based on the distribution chart, Dishman Carbogen Amics ranks #53 out of 1225 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dishman Carbogen Amics has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #53 out of 1225 companies for PB Ratio. This places Dishman Carbogen Amics in the top 4% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.92. Dishman Carbogen Amics' value of 0.46 is 84.2% below this benchmark. Historically, Dishman Carbogen Amics' own PB Ratio has ranged from 0.16 to 2.49 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 2.92, Dishman Carbogen Amics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.92, based on 1,225 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dishman Carbogen Amics's current PB Ratio of 0.46 is 84.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Dishman Carbogen Amics and its competitors. For the Biotechnology industry, the median PB Ratio is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dishman Carbogen Amics's current PB Ratio is 0.46, which is 16% below median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹237.37, compared to a current price of ₹197.64 — trading 16.7% below its estimated fair value. The current PB Ratio is 0.46, which is 16% below median its 10-year median of 0.55 and 84.2% below the Biotechnology industry median of 2.92. Dishman Carbogen Amics' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current PB Ratio is 0.46 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?
Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued.
The current stock price of ₹197.64 is trading 16.7% below its estimated GF Value™ of ₹237.37.
GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.
Key valuation signals for NSE:DCAL:
PB Ratio: 0.46 (16% below median its 10-year median of 0.55)
GF Value™: ₹237.37 vs. price of ₹197.64 (16.7% below fair value)
Industry Position: 84.2% below the Biotechnology median (#53 of 1225)
No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
70GF Score
Get the complete analysis for NSE:DCAL
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DCAL has been successfully added to your 
